MedPath

Sleep's Influence on the Treatment of Intrusive Emotional

Not Applicable
Completed
Conditions
PTSD
Intrusive Memories
Interventions
Behavioral: Sleep/Nap
Registration Number
NCT05678361
Lead Sponsor
University of Zurich
Brief Summary

Intrusive memories represent a debilitating core feature of PTSD, one of the most prevalent psychiatric disorders following trauma. Exposure therapy is amongst the most successful treatments of PTSD that is recommended by most of the current national and international guidelines. The current study aims to test whether sleep as adjunct to written exposure sessions, a type of exposure- based treatment for PTSD, may boost the effectiveness of the therapy.

Detailed Description

Intrusive memories represent a debilitating core feature of PTSD, one of the most prevalent psychiatric disorders following trauma. Exposure therapy is amongst the most successful treatments of PTSD that is recommended by most of the current national and international guidelines. However, not all patients benefit equally and only about 50% show sustained response. There is thus room for improvement in terms of (i) better understanding who benefits from this type of therapy and (ii) possible ways of augmenting existing trauma-focused therapies. The current study aims to contribute to these endevours. Specifically, the study aims to test whether sleep as adjunct to written exposure sessions, a type of exposure- based treatment for PTSD, may boost the effectiveness of the therapy.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
42
Inclusion Criteria
  • DSM V criteria of PTSD (at least moderate symptoms in two categories)
  • Currently receiving Written Exposure Therapy at one of the psychotherapy centers at the Psychiatric University Clinic (PUC).
  • Not more than moderate alcohol consumption (not more than 5 alcoholic drinks/week).
  • Ability to understand the study instructions
Exclusion Criteria
  • Travel over > 3 time zones in < 3 months
  • head injury
  • shift work
  • current substance abuse
  • neurological disease
  • drug addiction
  • Current suicidality

Specific exclusion criteria for the fMRI:

  • Acute psychotic symptoms
  • Pregnancy
  • Claustrophobia
  • Magnetic resonance imaging incompatibility:
  • Cardiac pacemaker or other metallic implants (e.g. metallic cardiac valve, insulin pump)
  • Metallic foreign particles (e.g. after bullet wound, shell splinter, clips, metal prostheses)

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Sleep after exposureSleep/NapParticipants take a nap during 90 min following three exposure (WET) sessions.
Primary Outcome Measures
NameTimeMethod
Clinician- assessed Posttraumatic stress symptom severity at 1 weekOne week post- treatment

Clinician- assessed PTSD symptom severity (CAPS- 5)

Self-reported Posttraumatic stress symptom severity at 1 weekOne week post- treatment

Self - reported PTSD symptom severity (PCL-5)

Clinician- assessed Posttraumatic stress symptom severity at 1 monthOne month post- treatment

Clinician- assessed PTSD symptom severity (CAPS- 5)

Self-reported Posttraumatic stress symptom severity at 1 monthOne month post- treatment

Self - reported PTSD symptom severity (PCL-5)

Secondary Outcome Measures
NameTimeMethod
Time spent in N2 sleepImmediately after written exposure therapy

N2 time according to EEG

Total sleep timeImmediately after written exposure therapy

Total sleep time according to EEG

Time spent in N1 sleepImmediately after written exposure therapy

N1 time according to EEG

Time spent in N3 sleepImmediately after written exposure therapy

N3 time according to EEG

Trial Locations

Locations (1)

Psychiatric University Hospital

🇨🇭

Zürich, Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath